Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
PGIM India Healthcare Fund Direct Growth
NAV: 13 Oct '26
₹11.93
Min. for SIP
₹1,000
Fund size (AUM)
₹130.32 Cr
Expense ratio
1.00%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,577 | -2.82% | |
| 6 months | ₹30,000 | ₹30,583 | +1.94% | |
| 1 year | ₹60,000 | ₹66,076 | +10.13% |
Holdings (33)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | Equity | 10.36% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.25% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 8.49% |
| Others CBLO | Unspecified | CBLO | 5.24% |
| Ajanta Pharma Ltd | Healthcare | Equity | 4.96% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.71% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 4.33% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.04% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 3.68% |
| Navin Fluorine International Ltd | Materials | Equity | 3.24% |
| Abbott India Ltd | Healthcare | Equity | 3.12% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 2.99% |
| Rubicon Research Ltd. | Healthcare | Equity | 2.99% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.91% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 2.56% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.54% |
| ICICI Lombard General Insurance Company Ltd | Financial | Equity | 2.10% |
| Cipla Ltd | Healthcare | Equity | 2.04% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.04% |
| Lupin Ltd | Healthcare | Equity | 1.93% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.92% |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | Equity | 1.86% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 1.81% |
| Global Health Ltd | Healthcare | Equity | 1.52% |
| Gland Pharma Ltd | Healthcare | Equity | 1.50% |
| Fortis Healthcare Ltd | Healthcare | Equity | 1.46% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 1.46% |
| Symbiotec Pharmalab Ltd. | Healthcare | Equity | 1.10% |
| Lenskart Solutions Ltd. | Consumer Discretionary | Equity | 0.99% |
| Molbio Diagnostics Ltd. | Healthcare | Equity | 0.80% |
| Orchid Pharma Ltd | Healthcare | Equity | 0.79% |
| Sagility India Ltd. | Industrials | Equity | 0.40% |
| Net Payables | Unspecified | Net Payables | -0.13% |
See All
Minimum investments
Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹1,000
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +0.6% | +20.1% | +18.7% | +19.3% |
| Category average (Equity Sectoral) | -1.9% | +14.8% | +12.1% | +176.2% |
| Rank (Equity Sectoral) | 6 | 3 | 3 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 0.50%, if redeemed within 90 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
APAAnandha Padmanabhan AnjeneyanNov 2024 - PresentView details
APA
Anandha Padmanabhan Anjeneyan
Nov 2024 - Present
View details
VSVivek SharmaNov 2024 - PresentView details
VS
Vivek Sharma
Nov 2024 - Present
View details
UMUtsav MehtaNov 2024 - PresentView details
UM
Utsav Mehta
Nov 2024 - Present
View details
PPPuneet PalNov 2024 - PresentView details
PP
Puneet Pal
Nov 2024 - Present
View details
About PGIM India Healthcare Fund Direct Growth
PGIM India Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by PGIM India Mutual Fund. This scheme was made available to investors on 13 May 2010. Anandha Padmanabhan Anjeneyan is the Current Fund Manager of PGIM India Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹27,127 Cr and the Latest NAV as of 13 Oct 2026 is ₹11.93.
The PGIM India Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹1,000. Minimum Lumpsum Investment is ₹5,000. Exit load of 0.50%, if redeemed within 90 days.
;
Investment Objective
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#26 in India
Total AUM₹27,126.69 Cr
Date of Incorporation13 May 2010
Launch Date13 May 2010
Address7th Floor, Radhe Empire,Chandavarkar RoadBorivali (W), Mumbai Mumbai 400092
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,